DECENTRALIZED TRIAL (DCT) TECHNOLOGY INSIGHTS
-
Not What I Expected From A Vendor ConferenceDan Schell recounts some of his key takeaways after attending the Veeva R&D Quality Summit in Boston in September 2024. Some of the topics discussed include DCTs, eCOA, and the need to simplify tech integration at sites.
-
Can DCTs Be Both Patient Centric And Financially Efficient For Sites?While DCTs have the potential to provide more convenience and improved access for patients, the anticipated cost savings touted for these trials have yet to materialize fully at the site level. In fact, the opposite has occurred in some instances.
DCT TECHNOLOGY VIDEOS
Accelerate clinical trial modernization with streamlined collection of continuous, high-precision data centered on the patient.
Dr. Andy Liu presents a case study determining which digital measure of physical activity would be a well-defined and reliable clinical endpoint in a trial including patients with diabetes.
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
How can wearable DHTs be leveraged to measure physical activity in patients with immunological diseases, enhancing clinical trials and advancing drug development?
DCT TECHNOLOGY RESOURCES
-
![Digital-Manufacturing-Supply-Chain-980x654]( "How Digital Therapeutics Tools Interact To Improve Patient Care")
This comprehensive overview illustrates the intersection between prescription digital therapeutics, digital health tools, and decentralized clinical trials in a remote care setting.
-
![Bright -ideas- innovation- inspiration-GettyImages-1371712788]( "How Small And Mid-Sized Biopharmaceutical Companies Can Easily Achieve Digital Innovation For Their Clinical Data")
Discover how forward- thinking life science companies are defining their vision and looking for like-minded partners to execute information technology.
-
![GettyImages-1346675623 biotech trends]( "What's Trending In The Biopharma And Biotech Industries")
With improved access to affordable digital technologies and a regulatory emphasis on diversity in patient recruitment, check out several highlights of the most notable projections in 2023.
-
![GettyImages-1163698800 patient ePRO]( "Trends Shaping The Pharmaceutical Industry's Future")
Decentralized trials and patient choice are key to expanding study reach. Here, we examine how patient access increases with diverse options and AI-powered connections across health systems and sites.
-
![GettyImages-1315159023 oncology ps]( "Mitigating The Risks Of Long-Term Oncology eCOA Clinical Trials")
This article digs into the specific complexities of long oncology clinical trials and describes relevant solutions to manage the risks regarding patient compliance, clinical project teams, and clinical sites.
-
![GettyImages-1248714799 audit]( "How Will IQVIA One Home for Sites™ Simplify Clinical Trial Technology?")
IQVIA Technologies leaders answer questions from sponsors, sites, CROs, and tech vendors about their aggregation platform that provides single sign-on across sponsors, studies, and systems.
-
![Mobile Device Management]( "Beyond The Pandemic: Why eCOAs Are Here To Stay")
The permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
